Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
MIAMI, July 17, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 73rd Emerging Growth Conference on July 17 & 18 2024. ...
-
MIAMI, July 16, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 73rd Emerging Growth Conference on July 17 & 18 2024. ...
-
New York, United States , June 13, 2024 (GLOBE NEWSWIRE) -- The Global Bipolar Disorder Market Size Expected to Grow from USD 5.32 Billion in 2023 to USD 6.47 Billion by 2033, at a CAGR of 1.98%...
-
ZTlido® is the most prescribed non-opioid, branded pain treatment prescribed by pain specialists.1Total ZTlido® NRx (New Drug Prescription) market share for the non-opioid branded pain treatment...
-
NEW YORK, July 18, 2023 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased NRx Pharmaceuticals Inc. (f/k/a Big Rock...
-
PHILADELPHIA, July 10, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) (“NRx”) on behalf of the company’s long-term shareholders....
-
NEW YORK, June 29, 2023 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased NRx Pharmaceuticals Inc. (f/k/a Big...
-
NRx Pharmaceuticals、Lotus Pharmaceuticals 和 Alvogen 将携手面向全球进一步开发和商业化用于治疗自杀倾向难治性双相抑郁症 (S-TRBD) 的 NRX-101 药物Lotus Pharmaceuticals 将获得用于治疗 S-TRBD 的 NRX-101 药物的全球使用权，并将负责通过 Lotus...
-
NRx Pharmaceuticals、Lotus Pharmaceuticals 與 Alvogen 將共同進一步針對全球市場開發及商品化 NRX-101，用於治療具自殺傾向的難治型雙極性憂鬱 (S-TRBD)Lotus Pharmaceuticals 會取得 S-TRBD 治療藥物 NRX-101 的全球性權利，並且負責處理 NRX-101...
-
NRx Pharmaceuticals, Lotus Pharmaceuticals et Alvogen collaborent au développement et à la commercialisation sur les marchés mondiaux du NRX-101, médicament pour la dépression bipolaire avec tendances...